These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23134937)
1. Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes. Hudson OD; Nunez M; Shaibi GQ BMC Pediatr; 2012 Nov; 12():174. PubMed ID: 23134937 [TBL] [Abstract][Full Text] [Related]
2. Ethnic differences in the link between insulin resistance and elevated ALT. Deboer MD; Wiener RC; Barnes BH; Gurka MJ Pediatrics; 2013 Sep; 132(3):e718-26. PubMed ID: 23940240 [TBL] [Abstract][Full Text] [Related]
3. Association of liver enzymes with incident diabetes in US Hispanic/Latino adults. Hua S; Qi Q; Kizer JR; Williams-Nguyen J; Strickler HD; Thyagarajan B; Daviglus M; Talavera GA; Schneiderman N; Cotler SJ; Cai J; Kaplan R; Isasi CR Diabet Med; 2021 Aug; 38(8):e14522. PubMed ID: 33434318 [TBL] [Abstract][Full Text] [Related]
4. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme. Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810 [TBL] [Abstract][Full Text] [Related]
5. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. Mohanty SR; Troy TN; Huo D; O'Brien BL; Jensen DM; Hart J J Hepatol; 2009 Apr; 50(4):797-804. PubMed ID: 19231016 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus. Judi L; Toukan A; Khader Y; Ajlouni K; Khatib MA Ann Saudi Med; 2010; 30(1):25-32. PubMed ID: 20103955 [TBL] [Abstract][Full Text] [Related]
7. Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Schneider AL; Lazo M; Ndumele CE; Pankow JS; Coresh J; Clark JM; Selvin E Diabet Med; 2013 Aug; 30(8):926-33. PubMed ID: 23510198 [TBL] [Abstract][Full Text] [Related]
8. Increased liver markers are associated with higher risk of type 2 diabetes. Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993 [TBL] [Abstract][Full Text] [Related]
9. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening. Poustchi H; Alaei-Shahmiri F; Aghili R; Nobarani S; Malek M; Khamseh ME Arch Iran Med; 2021 Mar; 24(3):177-186. PubMed ID: 33878875 [TBL] [Abstract][Full Text] [Related]
10. Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese men. Villegas R; Xiang YB; Elasy T; Cai Q; Xu W; Li H; Fazio S; Linton MF; Raiford D; Zheng W; Shu XO Metab Syndr Relat Disord; 2011 Aug; 9(4):305-11. PubMed ID: 21495862 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease. Tian F; Zheng Z; Zhang D; He S; Shen J Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30473540 [TBL] [Abstract][Full Text] [Related]
12. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Schwimmer JB; McGreal N; Deutsch R; Finegold MJ; Lavine JE Pediatrics; 2005 May; 115(5):e561-5. PubMed ID: 15867021 [TBL] [Abstract][Full Text] [Related]
13. Frequency of Disparities in Laboratory Testing After Statin Initiation in Subjects ≥65 Years. Maciejewski ML; Mi X; Curtis LH; Ng J; Haffer SC; Hammill BG Am J Cardiol; 2016 Aug; 118(3):376-82. PubMed ID: 27289297 [TBL] [Abstract][Full Text] [Related]
14. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Haffner SM; Howard G; Mayer E; Bergman RN; Savage PJ; Rewers M; Mykkänen L; Karter AJ; Hamman R; Saad MF Diabetes; 1997 Jan; 46(1):63-9. PubMed ID: 8971083 [TBL] [Abstract][Full Text] [Related]
15. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study. Zou Y; Zhong L; Hu C; Sheng G Lipids Health Dis; 2020 Nov; 19(1):245. PubMed ID: 33239040 [TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes. Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826 [TBL] [Abstract][Full Text] [Related]
17. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients. Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576 [TBL] [Abstract][Full Text] [Related]
18. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Hanley AJ; Williams K; Festa A; Wagenknecht LE; D'Agostino RB; Kempf J; Zinman B; Haffner SM; Diabetes; 2004 Oct; 53(10):2623-32. PubMed ID: 15448093 [TBL] [Abstract][Full Text] [Related]
19. Liver Enzymes, Fatty Liver and Type 2 Diabetes Mellitus in a Jinchang Cohort: A Prospective Study in Adults. Zhang J; Cheng N; Ma Y; Li H; Cheng Z; Yang Y; He C; Li J; Pu H; Shen X; Ren X; Shi D; Pu R; Gan T; Ding J; Zheng T; Bai Y Can J Diabetes; 2018 Dec; 42(6):652-658. PubMed ID: 29936075 [TBL] [Abstract][Full Text] [Related]
20. Ethnicity, alcohol drinking and changes in transaminase activity among heavy drinkers. Stewart SH; Connors GJ J Natl Med Assoc; 2007 May; 99(5):564-9. PubMed ID: 17534015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]